Seegene introduces STAgora at ESCMID Global 2026
21 Apr 2026
STAgora, real-time data analytics platform
Seegene, a global molecular diagnostics company, has launched STAgora™, a real-time data analytics platform based on aggregated statistical testing data, and presented an enhanced model of its automated PCR workflow concept CURECA™ at ESCMID Global 2026, held April 17–21 in Munich, Germany.
At the STAgora station, attendees experienced live simulations of the platform, demonstrating strong interest in its intuitive interface and aggregated data visualization capabilities.
Visitors explored real-time dashboards presenting comparative data between single-target and syndromic PCR testing outputs, regional infection trends over time, pathogen-specific positivity rates and co-infection patterns. The ability to analyze aggregated test results alongside regional epidemiological data drew particular attention from attendees.
Seegene presented its key message, “From Numbers to Insights”, highlighting how automated testing infrastructure and real-time data analytics can work together to support a better understanding of population-level and public health-related trends.
Seegene also showcased an enhanced model of CURECA. Visitors examined the system’s modular structure and automation workflow, which integrates preprocessing, nucleic acid extraction, amplification, and result processing. Many attendees engaged in discussions about the system’s architecture and its applicability in real laboratory environments.
“STAgora is designed to connect PCR testing data generated around the world in real time and provide a clearer view of infectious disease trends based on aggregated statistics,” said Young Seag Baeg, New Business Officer at Seegene.
“We are continuing to explore how real-time data analytics, combined with automated testing infrastructure, can help laboratories better understand infection patterns and expand the practical use of aggregated testing data.”
“Interest in STAgora’s real-time data capabilities and practical applications was strong throughout the event,” said Daniel Shin, Executive Vice President and Chief Global Sales and Marketing Officer at Seegene. “We plan to expand pilot programs and collaborative evaluations with healthcare and laboratory institutions to further evaluate the platform and support its potential future adoption.”